Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-19

Clinical Trial Update: Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Tropicamide 0.5% versus Tropicamide 1% on intraocular pressure in patients with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tropicamide 0.5% (tropicamide)
  • Tropicamide 1% (tropicamide)

Snippet

Sponsor: Semnan University of Medical Sciences | Conditions: Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED